维普中文期刊产品整合服务
66篇 您的检索式:作者名="MADEDDU G"
    题名 作者 年代 出处 被引量
1Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases 显示文摘Emanueli G Madeddu P 2004Arch Mal Coeur2004,97,6:1
2Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients:assessment of the most important laboratory indexes of cachexia and oxidative stress显示文摘Mantovani G Maccio A Madeddu C 2003J Mol Med2003,81,10:1
3Tenofovir renal safety in HIV-infected patients : Results from the SCOLTA Project 显示文摘Madeddu G Bonfanti P de Socio GV 2008Biomed Pharmacother2008,62,1:1
4Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment显示文摘Mantovani G Maccio A Madeddu C 2003J Environ Pathol Toxicol Oncol2003,22,1:1
5Phase Ⅱ nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia显示文摘Mnntovani G Maccio A Madeddu C 2010J Mol Med (Berl)2010,88,1:1
6Diet and nutrients are contributing factors that influence blood cadmium levels 显示文摘MADEDDU R SOLINAS G FORTE G 2011Nutr Res2011,31,9:1
7Quantitative evaluation of oxidative stress,chronic inflammatory indices and leptin in cancer patients:correlation with stage and performance status显示文摘Mantovani G Maccio A Madeddu C 2002Int J Cancer2002,98,1:1
8sestamibi andtetrofosmin in oncology:SPET and fusion imaging in lung cancer,malignant lymphomas and brain tumors显示文摘Schillaci O Spanu A Madeddu G 2005Q J Nucl Med Mol Imaging2005,49,2:1
9Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications显示文摘Maccib A Madeddu C Gramignano G 2010J Mol Med (Berl)2010,88,7:1
10Adipose tissue as target organ in the treatment of hormone - dependent breast cancer: new therapeutic perspectives 显示文摘Maceio A Madeddu C Mantovani G 2009Obesity Reviews2009,10,6:1
11Phase Ⅱ nonrandomized study of the efficacy and safety of COX - 2 inhibitor celecoxib on patients with cancer cachexia显示文摘Mantovani G Maccio A Madeddu C 2010J Mol Med2010,88,1:1
12Efficacy and safety of oral laetoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer pa- tients undergoing chemotherapy: open-label, randomized con- trolled study显示文摘MACCIO A MADEDDU C GRAMIGNANO G 2010Oncologist2010,15,8:1
13Genetically engineered stem cell therapy for tissue regeneration显示文摘Alessandri G Emanueli C Madeddu P 2004Ann NY Acad Sci2004,1015,:1
14lmmunotherapy (recom- binant interleukin 2 ) , hormone therapy ( medroxyprogesteroae ace- tate) and antioxidant agents as combined maintenance treatment of re- sponders to previous chemotherapy 显示文摘Mantovni G Maccio A Madeddu C 2001Int J Oncol2001,18,2:1
15A phase Ⅱ study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cydooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress显示文摘Mantovani G Maccio A Madeddu G 2006Cancer Epidemiol Biomarkers Prey2006,15,5:1
16Genetically engineered stem cell therapy for tissue regeneration显示文摘Alessandri G Emanueli C Madeddu P 0,,:1
17Efficacy of 1-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 显示文摘Gramignano G Lusso MR Madeddu C 2006Nutrition2006,22,2:1
18Phase Ⅱ nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 显示文摘Mantovani G Maccio A Madeddu C 2010J Mol Med2010,88,1:1
19Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients : Correlation with stage and performance status显示文摘Mantovani G Antonio Macci 6 Clolia Madeddu 2002International Journal of Cancer2002,98,1:1
20HPV infection in I-IIV-positivefemales: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 显示文摘Madeddu G Mameli G Mura M 2014Eur Rev Med Pharmacol Sci2014,18,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费